Facility size and mortality in hospital-based and freestanding haemodialysis units: A nationwide retrospective cohort study.


Journal

Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568

Informations de publication

Date de publication:
Nov 2019
Historique:
accepted: 27 11 2018
pubmed: 1 12 2018
medline: 31 3 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

Existing studies on the association between haemodialysis facility size/volume and patient survival are mostly limited to freestanding dialysis units in the United States. This study in Taiwan explored the facility size - mortality association in both hospital-based and freestanding haemodialysis (HD) units. In this nationwide population-based retrospective cohort study, we used the Taiwan National Health Insurance Research Database to include patients who began maintenance (HD) between 2008 and 2012. Facility size was categorized according to the number of stations in the HD unit. The 5 years mortality rate was analyzed using a frailty model for Cox regression. The patients in hospital-based and freestanding HD units were examined separately. Among the 39 506 patients, 24 597 (62.3%) and 14 909 (37.7%) patients received HD in hospital-based and freestanding facilities, respectively. After the 4th month of dialysis initiation, the 5 years survival rates of patients in hospital-based and freestanding HD units were 50.7% and 52.3%, respectively. When patient and other facility characteristics were adjusted, patients in the smallest facility category (1-15 stations) showed the highest mortality risk (hazard ratio, 1.36; 95% confidence interval, 1.11-1.67) among all the patients treated in hospital-based units. The patients treated in freestanding units with 1-15, 16-30 and 31-45 stations showed 31%, 33% and 36%, respectively, higher mortality risks than those of patients treated in units with more than 45 stations. A small facility size was associated with an increased mortality risk in HD patients, and the threshold size was higher in freestanding units.

Identifiants

pubmed: 30499206
doi: 10.1111/nep.13543
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1157-1164

Subventions

Organisme : National Health Research Institutes

Informations de copyright

© 2018 Asian Pacific Society of Nephrology.

Références

System USRD. USRDS 2016 Annual Data Report: Atalas of Chronic Kidney Disease and End-Stage Renal Disease in the United States: National Institute of Health. Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Disease, 2016.
Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 1999; 341: 1725-30.
Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am. J. Kidney Dis. 2001; 38: 443-64.
II. NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: Update 2000. Am. J. Kidney Dis 2001; 37: S65-s136.
I. NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: Update 2000. Am. J. Kidney Dis. 2001; 37: S7-s64.
Clinical practice guidelines for peritoneal dialysis adequacy. Am. J. Kidney Dis. 2006; 48: S98-129.
Clinical practice guidelines for hemodialysis adequacy, update 2006. Am. J. Kidney Dis. 2006; 48: S2-90.
Blake PG, Bargman JM, Brimble KS et al. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit. Dial. Int. 2011; 31: 218-39.
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am. J. Kidney Dis. 2015; 66: 884-930.
Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J. Am. Soc. Nephrol. 2003; 14: 3270-7.
McClellan WM, Flanders WD, Gutman RA. Variable mortality rates among dialysis treatment centers. Ann. Intern. Med. 1992; 117: 332-6.
Eisenstein EL, Sun JL, Anstrom KJ et al. Re-evaluating the volume-outcome relationship in hemodialysis patients. Health Policy 2008; 88: 317-25.
Held PJ, Pauly MV, Diamond L. Survival analysis of patients undergoing dialysis. JAMA 1987; 257: 645-50.
Yan G, Norris KC, Xin W et al. Facility size, race and ethnicity, and mortality for in-center hemodialysis. J. Am. Soc. Nephrol. 2013; 24: 2062-70.
Erickson KF, Tan KB, Winkelmayer WC, Chertow GM, Bhattacharya J. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin. J. Am. Soc. Nephrol. 2013; 8: 987-94.
Wu TY, Majeed A, Kuo KN. An overview of the healthcare system in Taiwan. London J. Prim. Care (Abingdon). 2010; 3: 115-9.
Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J. Clin. Epidemiol. 1993; 46: 1075-9 discussion 81-90.
Murphy SA. Consistency in a proportional hazards model incorporating a random effect. Ann. Stat. 1994; 22: 712-31.
Austin PC. A tutorial on multilevel survival analysis: Methods, models and applications. Int. Stat. Rev. 2017; 85: 185-203.
Plough AL, Salem SR, Shwartz M, Weller JM, Ferguson CW. Case mix in end-stage renal disease. Differences between patients in hospital-based and free-standing treatment facilities. N. Engl. J. Med. 1984; 310: 1432-6.
Yan G, Norris KC, Greene T et al. Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis. Clin. J. Am. Soc. Nephrol. 2013; 24:2062-70.
Kawaguchi T, Karaboyas A, Robinson BM et al. Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J. Am. Soc. Nephrol. 2013; 24: 1493-502.
Slinin Y, Guo H, Li S et al. Association of provider-patient visit frequency and patient outcomes on hemodialysis. J. Am. Soc. Nephrol. 2012; 23: 1560-7.
Mesman R, Westert GP, Berden BJMM, Faber MJ. Why do high-volume hospitals achieve better outcomes? A systematic review about intermediate factors in volume-outcome relationships. Health Policy 2015; 119: 1055-67.
Begg CB, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N. Engl. J. Med. 2002; 346: 1138-44.
Birkmeyer JD, Siewers AE, Finlayson EVA et al. Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 2002; 346: 1128-37.
Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N. Engl. J. Med. 1979; 301: 1364-9.
Marcin JP, Li Z, Kravitz RL, Dai JJ, Rocke DM, Romano PS. The CABG surgery volume-outcome relationship: Temporal trends and selection effects in California, 1998-2004. Health Serv. Res. 2008; 43: 174-92.
Peterson ED, Coombs LP, DeLong ER, Haan CK, Ferguson TB. Procedural volume as a marker of quality for CABG surgery. JAMA 2004; 291: 195-201.
Farley DE, Ozminkowski RJ. Volume-outcome relationships and in-hospital mortality: The effect of changes in volume over time. Med. Care 1992; 30: 77-94.
Lindenauer PK, Behal R, Murray CK, Nsa W, Houck PM, Bratzler DW. Volume, quality of care, and outcome in pneumonia. Ann. Intern. Med. 2006; 144: 262-9.
Ross JS, Normand S-LT, Wang Y et al. Hospital volume and 30-day mortality for three common medical conditions. N. Engl. J. Med. 2010; 362: 1110-8.
McClellan WM, Frankenfield DL, Frederick PR, Helgerson SD, Wish JB, Sugarman JR. Improving the care of ESRD patients: A success story. Health Care Financ. Rev. 2003; 24: 89-100.
Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch. Intern. Med. 2012; 172: 1071-7.
Chukmaitov AS, Menachemi N, Brown LS, Saunders C, Brooks RG. A comparative study of quality outcomes in freestanding ambulatory surgery centers and hospital-based outpatient departments: 1997-2004. Health Serv. Res. 2008; 43: 1485-504.

Auteurs

Yen-Hung Yao (YH)

Division of Nephrology, Department of Medicine, National Yang-Ming University Hospital, Taipei, Taiwan.
Institute of Public Health, National Yang-Ming University, Taipei, Taiwan.

Yiing-Jenq Chou (YJ)

Institute of Public Health, National Yang-Ming University, Taipei, Taiwan.
School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Nicole Huang (N)

Institute of Hospital and Health Administration, National Yang-Ming University, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH